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Association between gut dysbiosis and neurogenic diseases, such as hypertension,
has been described. The aim of this study was to investigate whether changes in
the gut microbiota alter gut-brain interactions inducing changes in blood pressure
(BP). Recipient normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats
(SHR) were orally gavaged with donor fecal contents from SHR and WKY. We divided
the animals into four groups: WKY transplanted with WKY microbiota (W-W), SHR
with SHR (S-S), WKY with SHR (W-S) and SHR with WKY (S-W). Basal systolic
BP (SBP) and diastolic BP (DBP) were reduced with no change in heart rate as
a result of fecal microbiota transplantation (FMT) from WKY rats to SHR. Similarly,
FMT from SHR to WKY increased basal SBP and DBP. Increases in both NADPH
oxidase-driven reactive oxygen species production and proinflammatory cytokines in
brain paraventricular nucleus linked to higher BP drop with pentolinium and plasmatic
noradrenaline (NA) levels were found in the S-S group as compared to the W-W
group. These parameters were reduced by FMT from WKY to SHR. Increased levels
of pro-inflammatory cytokines, tyrosine hydroxylase mRNA levels and NA content in the
proximal colon, whereas reduced mRNA levels of gap junction proteins, were found in
the S-S group as compared to the W-W group. These changes were inhibited by FMT
from WKY to SHR. According to our correlation analyses, the abundance of Blautia and
Odoribacter showed a negative correlation with high SBP. In conclusion, in SHR gut
microbiota is an important factor involved in BP control, at least in part, as consequence
of its effect on neuroinflammation and the sympathetic nervous system activity.
Keywords: gut dysbiosis, hypertension, oxidative stress, neuroinflammation, sympathetic nervous system
Abbreviations: BM, bone marrow; BP, blood pressure; DBP, diastolic blood pressure; DHE, dihydroethidium; DNA,
deoxyribonucleic acid; FMT, fecal microbiota transplantation; GPR, G-protein-coupled receptor; HR, heart rate; IFN,
interferon; IL, interleukin; LPS, lipopolysaccharide; MUC, mucin; NA, noradrenaline; O2−, superoxide anion; of TH, tyrosine
hydroxylase; Olfr, olfactory receptor; PRA, plasma renin activity; PVN, paraventricular nucleus; ROS, reactive oxygen species;
RT-PCR, reverse transcriptase-polymerase chain reaction; SBP, systolic blood pressure; SCFAs, short-chain fatty acids; SHR,
spontaneously hypertensive rats; SNS, sympathetic nervous system; TLR, toll-like receptor; TNF-α, tumor necrosis factor-α;
WKY, Wistar-Kyoto; ZO, zonula occludens.
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INTRODUCTION
Abundant evidence has demonstrated the association between
gut dysbiosis and neurogenic diseases, such as hypertension
(Mell et al., 2015; Yang et al., 2015). A common characteristic of
resistant hypertension is chronically elevated sympathetic
nervous system (SNS) activity accompanied by a high
release of noradrenaline (NA) (Tsioufis et al., 2011), which
indicates a neurogenic component that contributes to the
initiation, maintenance and progression of hypertension
(Yang and Zubcevic, 2017).
The factors that stimulate sympathetic tone in human
essential hypertension are poorly understood. A newly identified
interaction between the brain, gut and bone has been identified
as a possible mechanism in the pathogenesis of hypertension
(Santisteban et al., 2016). For instance, an increase in sympathetic
drive to bone marrow (BM) and the gut may also trigger a
sequence of signaling events that can, ultimately, contribute to
an overall increase in blood pressure (BP) and the establishment
of hypertension, by affecting the structure and function of BP
target organs, such as vasculature, kidney, heart, and brain.
Increased sympathetic activity to the gut could result in dysbiosis,
increased gut permeability and inflammatory status, leading to an
imbalance in the gut content of short-chain fatty acids (SCFAs)-
producing bacteria and in the plasma levels of lipopolysaccharide
(LPS). These metabolic and structural microbial products,
working together, elevate sympathetic drive to the BM and
other lymphoid organs, and may act as modulators for BM cell
activity by increasing the proliferation and release of myeloid
progenitors and other pro-inflammatory cells. This increase in
myeloid progenitor cells contributes to an increase in peripheral
and central inflammation that could be a critical event for the
establishment of hypertension.
The immune and sympathetic systems are recognized
to contribute to the development of hypertension
(Yang et al., 2017), while there exists a bidirectional signaling
between the brain and gut microbiota which can regulate the
BP through the modulation of the interaction between SNS and
immune system (Yang and Zubcevic, 2017). Therefore, since
a link between hypertension and gut dysbiosis has recently
been suspected (Mell et al., 2015; Yang et al., 2015), several
groups are investigating this interaction. In this way, different
studies have shown that fecal microbiota transplantation
(FMT) from hypertensive human and rat donors elevate the
BP of the host, normotensive mice and rats, respectively
(Adnan et al., 2017; Li et al., 2017; Toral et al., 2018), pointing
out that gut dysbiosis plays a possible contributing or even
causal role in hypertension. However, the communication
between gut microbiota and the SNS in hypertension is not
completely understood. We hypothesize that an increased
sympathetic activity contributes to gut dysbiosis, which then
increases inflammation and sympathetic activity. Because of
this, in the present study, we tested whether changes in gut
microbiota composition induced by reciprocal fecal microbiota
transplantation from Wistar-Kyoto (WKY) to spontaneously
hypertensive rats (SHR), could decrease neuroinflammation and
sympathetic activity and thereby lower BP. We used SHR as a
model of neurogenic hypertension characterized by sustained
age-dependent elevation in sympathetic activity and dysbiosis
(Judy et al., 1976; Yang and Zubcevic, 2017).
MATERIALS AND METHODS
Animals and Experimental Groups
This research was performed according to the National Institutes
of Health (NIH) Guide for the Care and Use of Laboratory
Animals, and approved by the Ethic Committee of Laboratory
Animals of the University of Granada, Spain (Ref. 03-CEEA-
OH-2013). Male SHR and WKY were obtained from Harlan
Laboratories (Barcelona, Spain). All rats were fed standard rat
chow (Harlan global diet 2014, Harlan Laboratories, Inc., Milan,
Italy) ad libitum for the duration of the experiment. Stool samples
were collected and pooled from twenty-week-old WKY and SHR
rats. Donor fecal contents were administered through oral gavage
to twenty-five-weeks-old WKY and SHR rats for 3 consecutive
days, and once every 3 days for a total extension of 4 weeks.
Animals were randomly assigned to four different groups of 5–
8 animals each: WKY with WKY microbiota (W-W), WKY with
SHR (W-S), SHR with SHR (S-S) and SHR with WKY (S-W).
Rats were kept in individually ventilated cages in a pathogen-free
animal facility. Body weight, food and water intake were recorded
weekly for all groups. During the experimental periods, rats had
free access to tap water and chow. FMT to recipient rats were
carried out as previously reported with several modifications
(Bruce-Keller et al., 2015).
Fecal Microbiota Transplantation (FMT)
Fecal icrobiota transplantation to recipient rats was carried
out as previously reported with several modifications
(Toral et al., 2018). Briefly, fecal contents were isolated and
pooled from WKY rats and SHR (n = 5). Fecal contents were
diluted 1:20 in sterile PBS and centrifuged at 800 rpm for
5 min. The supernatant was aliquoted and stored at −80◦C.
Starting 1 week before the administration, recipient rats were
administered with 1 mL ceftriaxone sodium (400 mg/Kg/day)
daily for five consecutive days by oral gavage. The purpose of the
antibiotic treatment was to reduce the pre-existing microbiota
and to facilitate the recovery of the population and diversity of
intestinal microbiota from donor rats after FMT (Li et al., 2017).
Forty-eight hours after the last antibiotic treatment, recipient
rats were orally gavaged with donor fecal contents (1 mL) as
explained above.
Blood Pressure Measurements
Systolic blood pressure (SBP) and heart rate (HR) was measured
weekly at room temperature using tail-cuff plethysmography
as described previously (Zarzuelo et al., 2011). At the end of
the experimental period, animals were subjected to isoflurane
anesthesia, a polyethylene catheter containing 100U heparin in
isotonic, sterile NaCl solution was inserted in the left carotid
artery to monitor intra-arterial BP. Twenty-four hours after
the implantation of the catheter, we recorded intra-arterial
BP uninterruptedly for 60 min with a sampling frequency of
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400/s (McLab; AD Instruments, Hastings, United Kingdom).
For intergroup comparisons, BP values recorded during the last
30 min were averaged.
Evaluation of the Contribution of
Sympathetic Activity
Acute BP responses to intravenous injection of pentolinium
(10 mg/Kg) were analyzed in conscious rats. Before pentolinium
administration, arterial blood samples (0.2 mL) were drawn via
the catheter to measure NA levels and plasma renin activity
(PRA). The pentolinium dose was selected because it produces
maximal sympathetic inhibition (Pechánová et al., 2004). Finally,
the rats were subjected to isoflurane anesthesia and were killed
by complete exsanguination, then the brain was removed, snap-
frozen in liquid nitrogen, and stored at−80◦C until processed for
the reverse transcriptase-polymerase chain reaction (RT-PCR)
measurement (Romero et al., 2016).
Plasma and Colonic Determinations
Blood samples were cooled in ice and centrifuged for 10 min
at 3,500 rpm at 4◦C, and the plasma was frozen at −80◦C.
Plasma LPS concentration was measured using the Limulus
Amebocyte Lyste (LAL) chromogenic endotoxin quantitation Kit
(Lonza, Valais, Switzerland), according to the instructions of
the manufacturer.
We used enzyme-linked immunosorbent assay kits (IBL
International, Hamburg, Germany) to measure both plasma
and colonic NA concentrations following the manufacturer’s
protocol. Colon samples were collected and immersed in the
appropriate conservation solution. EDTA 1 mM and sodium
metabisulfite 4 mM were added to prevent the catecholamine
degradation, then plasma and tissue samples were stored at
−80◦C for later use.
The Rat Renin Activity Fluorometric Assay Kit (BioVision,
Milpitas, CA, United States; K806-100) was used to measure the
renin activity following the manufacturer’s protocol.
Measurement of Intracellular Reactive
Oxygen Species (ROS) Concentrations
Reactive oxygen species production was measured in
homogenates from brain paraventricular nucleus (PVN)
using the fluorescent probe 5-(and-6-)chloromethyl-2′-7′-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA). Brain
PVN was homogenized in lysis buffer composed of 50 mM
Tris–HCl (pH 7.4) containing 0.1 mM EDTA, 0.1 mM EGTA,
10 µg/mL aprotinin, 10 µg/mL leupeptin and 1 mM PMSF.
Fresh homogenates (10 µg of protein) in 96-well plates were
incubated with 5 µmol/L CM-H2DCFDA for 30 min at 37◦C, in
the absence or in the presence of the NADPH oxidase inhibitor
apocynin (50 µM). The fluorescent intensity was measured using
a spectrofluorimeter (Fluorostart, BMG Labtech, Ortenberg,
Germany) (Toral et al., 2015).
NADPH Oxidase Activity
The NADPH oxidase activity in homogenates from brain
PVN was measured by dihydroethidium (DHE) fluorescence
assay in the microplate reader, as described previously
(Fernandes et al., 2007; Toral et al., 2015). Fresh homogenates
(10 µg of protein) were incubated with DHE (10 µM) and
deoxyribonucleic acid (DNA, 1.25 µg/mL) in PBS (100 mM),
pH 7.4, containing 100 µM DTPA with the addition of NADPH
(50 µM), at a final volume of 120 µL. Incubations were
performed for 30 min at 37◦C in the dark. Total fluorescence
was followed in a microplate reader using a rhodamine filter
(excitation 490 nm and emission 590 nm) in a spectrofluorometer
(Fluorostart, BMG Labtech, Ortenberg, Germany).
RT-PCR Analysis
For RT-PCR analysis, total RNA was extracted from the
colon, and brain PVN by homogenization and converted
to cDNA by standard methods. PVN and colon tissue
was homogenized in 1 ml of TRI Reagent (Thermo Fisher
Scientific Inc., Waltham, MA, United States). RNA isolation
was performed with traditional methods using sequential
washes with bromochloropropane, isopropanol and ethanol
75%. RNA concentrations were measured with a NanoDropTM
2000 Spectrophotometer (Thermo Fisher Scientific Inc.,
Waltham, MA, United States). A Techne Techgene thermocycler
(Techne, Cambridge, United Kingdom) was used to perform
the polymerase chain reaction. mRNA expression was
analyzed through quantitative real-time RT-PCR. RNA was
reverse transcribed using oligo (dT) primers, Recombinant
RNasin R© Ribonuclease, dNTP (10 mM) and M-MLV reverse
Transcriptase (Promega, Southampton, United Kingdom).
Reverse resulting cDNA (2 ng) was amplified on optical
grade 48-well plates in an EcoTM Real-Time PCR System
(Illumina, CA, United States), using GoTaq R© qPCR Master
Mix, 2x (Promega, Southampton, United Kingdom). In
Table 1 are listed the sequences of both sense and antisense
primers used for amplification. In order to determine non-
saturating conditions of PCR amplification for all genes
studied, preliminary experiments with various amounts of
cDNA were performed. Under these conditions, RT-PCR
method was used to assess the relative quantification of mRNA.
A standard tissue sample was used to determine the efficiency
of the PCR reaction. The 11Ct method was performed
for quantification. The housekeeping gen glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used for internal
normalization (Romero et al., 2016).
16S rDNA V4-V5 Region Sequencing
Fecal DNA was extracted from the samples collected from
5 to 6 animals per group by using a quick-DNA fecal/soil
microbe kit (Zymo Research, Irvine, CA). Primers compatible
with illumina Miseq v2 2x250bp kit (Illumina, San Diego, CA)
were used to amplify bacterial 16S V4–V5 variable regions
(Robles-Vera et al., 2018). The PCR amplicons were purified
using a QIAquick gel extraction kit (QIAGEN, Hilden, Germany)
and quantified by Qubit (thermos Fisher Scientific, Waltham,
MA, United States). Equal amounts of purified PCR product
from each sample were pooled together as one library. The
library was quantified by real time PCR (Kapa Biosystems,
Wilmington, MA, United States) prior to Miseq sequencing
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TABLE 1 | Oligonucleotides for real-time RT-PCR.
mRNA targets Descriptions Sense Antisense
NOX-1 NOX-1 subunit of NADPH oxidase TCTTGCTGGTTGACACTTGC TATGGGAGTGGGAATCTTGG
NOX-4 NOX-4 subunit of NADPH oxidase ACAGTCCTGGCTTACCTTCG TTCTGGGATCCTCATTCTGG
p22phox p22phox subunit of NADPH oxidase GCGGTGTGGACAGAAGTACC CTTGGGTTTAGGCTCAATGG
p47phox p47phox subunit of NADPH oxidase CCCAGCGACAGATTAGAAGC TGGATTGTCCTTTGAGTCAGG
TNF-α Tumor necrosis factor-alpha ACGATGCTCAGAAACACACG CAGTCTGGGAAGCTCTGAGG
IL-6 Interleukin-6 GATGGATGCTTCCAAACTGG AGGAGAGCATTGGAAGTTGG
IL-10 Interleukin-10 GAATTCCCTGGGAGAGAAGC GCTCCACTGCCTTGCTTTTA
IL-17a Interleukin-17a CTTCACCTTGGACTCTGAGC TGGCGGACAATAGAGGAAAC
IFNγ Interferon gamma GCCCTCTCTGGCTGTTACTG CCAAGAGGAGGCTCTTTCCT
cd11b Cd11b GAGAACTGGTTCTGGCTTGC TCAGTTCGAGCCTTCTT
CCL2 C-C chemokine ligand 2 CCTCCACCACTATGCAGGTC CAGCCGACTCATTGGGATCA
Olfr59 Olfactory receptor 59 CTGCTAGTCATGGGTGTAGATG CAAGGGTGATAGAACGGTAAGG
GPR-41 G-protein-coupled receptor-41 TGACGGTGAGCATAGAACGTTT GCCGGGTTTTGTACCACAGT
GPR-43 G-protein-coupled receptor-43 TCGTGGAAGCTGCATCCA GCGCGCACACGATCTTT
Occludin Occludin AGCCTGGGCAGTCGGGTTGA ACACAGACCCCAGAGCGGCA
Muc2 Mucin-2 CGATCACCACCATTGCCACTG ACCACCATTACCACCACCTCAG
ZO-1 Zonula occludens-1 GCCAGCCAGTTCCGCCTCTG AGGGTCCCGGGTTGGTG
IL-1β Interleukin-1 beta GTCACTCATTGTGGCTGTGG GCAGTGCAGCTGTCTAATGG
TH Tyrosine hydroxylase GATTGCTACCTGGAAGGAGGT AGTCCAATGTCCTGGGAGAAC
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA
(Illumina, San Diego, CA, United States). The sequencing data
had a Q30 score ≥ 93.5% and 97.17 ± 0.34% of total cluster
passes the filter.
Bioinformatics Analysis
The raw paired-reads from Miseq were processed using
QIIME 1.9.1. Briefly, reads were trimmed to remove bases
with Phred scores lower than 30 and quality-filtered with
parameters set as previously optimized (ref: Quality-filtering
vastly improves diversity estimates from Illumina amplicon
sequencing). Open reference OTU-picking was performed and
taxonomical assignment to the generated OTUs were performed
with 97% identity against Greengenes database 13.8. Alpha
diversity and unweighted principal coordinate analyses plots
using the phylogenic tree-based unifrac distance metric were
generated using scripts from QIIME package.
Reagents
All reagents were purchased from Sigma-Aldrich (Barcelona,
Spain) unless otherwise specified.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 7
software. Results are expressed as means ± SEM. To test if
the values come from a gaussian distribution a Shapiro-Wilk
normality test was used. For comparisons of the four groups
with two variables (strain and treatment) we used a two-way
ANOVA (with Sidak’s correction for comparison of multiple
means). Factors were partitioned into strain (WKY-SHR) and
FMT (from WKY/from SHR). A p value of less than 0.05 was
considered significant considering the main effects of the strain
(WKY-SHR), FMT (from WKY/from SHR) and their interaction
(I; strain vs. FMT).
RESULTS
BP Is Controlled by Gut Microbiota
Fecal exchange from SHR to WKY enhanced basal SBP
(149.8 ± 4 mm Hg) by 16 ± 2 mm Hg (pFMT < 0.01), measured
by tail-cuff plethysmography. Similarly, FMT from WKY rats
to SHR lowered SBP by 38 ± 4 mm Hg (pFMT < 0.01) the
basal (199.5 ± 6 mm Hg, pstrain < 0.01) (Figure 1A) resulting
in a significant strain versus FMT interaction (pi < 0.05). In
conscious rats, direct SBP and DBP values were also increased
by FMT from SHR to WKY as compared to the W-W group
(pFMT < 0.01), and reduced in SHR after FMT from WKY as
compared to FMT from SHR to SHR (pFMT < 0.01), leading
to a significant strain versus FMT interaction (pi < 0.05). No
significant changes (pFMT = 0.62, pstrain = 0.44) were observed
among all experimental groups in HR obtained by direct register
(Figure 1B). No interaction was observed between strain and
FMT (pi = 0.39).
Sympathetic Activity, Brain PVN NADPH
Oxidase, Inflammation, and
Macrophages and T Cells Infiltration Are
Regulated by Gut Microbiota
We used a ganglionic blocker, pentolinium, in conscious rats
to determine the effect of FMT on sympathetic outflow. The
reduction on SBP after ganglionic blockade was higher in the
S-S group as compared to the W-W group (−113.3 ± 5.3 mm
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FIGURE 1 | Effects of fecal microbiota transplantation (FMT) on blood pressure. Systolic blood pressure (SBP), measured by tail-cuff plethysmography during
4 weeks of FMT (A), and SBP, diastolic blood pressure (DBP), and heart rate (HR), measured by direct register (B), in spontaneously hypertensive rats (SHR) with
stool transplant from SHR (S-S) or from Wistar Kyoto rats (WKY) (S-W) and in WKY with stool transplant from WKY (W-W) or from SHR (W-S) at the end of the
experimental period. Strain factor, FMT factor and I interaction between strain and FMT factors. ++p < 0.01, +p < 0.05 and ns (not significant) for the probability
based on a two-way analysis of variance. Values are means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. W-W; ##P < 0.01 vs. S-S statistical significance for the
probability based on a Sidak’s correction multiple comparisons test.
Hg vs. −59.8 ± 2.5 mm Hg, pstrain < 0.01). FMT from
WKY to SHR inhibited of the decay in SBP after pentolinium
(−83.6 ± 4.1 mm Hg, pFMT < 0.01) as compared to the S-S
group, whereas in W-S rats this reduction was also higher
(−79.4 ± 3.6 mm Hg, pFMT < 0.05) than that found in the W-W
group (Figure 2A), which led to a significant strain versus FMT
interaction (pi < 0.05). Similar qualitative changes among groups
in DBP reductions after pentolinium injection were observed
(pstrain < 0.01, pFMT < 0.01), without interaction between strain
and FMT (pi = 0.83). No changes in HR reductions (pFMT = 0.24,
pstrain = 0.63) and no interaction were observed between strain
and FMT (pi = 0.42) (Figure 2A). Plasma NA concentration
(pstrain < 0.01), another marker of sympathetic nerve activity,
was reduced ≈ 65 % by FMT from WKY to SHR (pFMT < 0.05)
and increased ≈ 2.5 times by FMT from SHR to WKY rats
(pFMT < 0.05) (Figure 2B). PRA was found ≈ 2 times higher in
the S-S groups as compared to the W-W group (pstrain < 0.05).
However, neither FMT from SHR to WKY increased PRA, as
compared with W-W, nor FMT from WKY significantly reduced
PRA as compared with S-S group (pFMT = 0.52) (Figure 2C),
which not led to a significant strain versus FMT interaction (NA
concentration: pi = 0.46; PRA: pi = 0.55).
We found that ROS production (pstrain < 0.01) (Figure 3A),
NADPH oxidase activity (pstrain < 0.01) (Figure 3B) and the
mRNA levels of NADPH oxidase subunits, NOX-1, NOX-
4, p47phox, and p22phox (pstrain < 0.01) (Figure 3C) and
pro-inflammatory cytokines (tumor necrosis factor-α (TNF-α),
interleukin (IL)-1β, IL-6, IL-17a, and interferon (IFN)-γ
(pstrain < 0.01) (Figures 4A–E) in brain PVN were higher
in the S-S group than those found in the W-W group, and
were reduced by FMT from WKY rats to SHR (pFMT < 0.05).
However, these patterns did not led to a significant strain
versus FMT interaction. By contrast, the anti-inflammatory
cytokine IL-10 was reduced in the S-S group as compared
to the W-W group (pstrain < 0.05) and increased after FMT
from WKY to SHR (pFMT < 0.05) (Figure 4F) leading
to a significant strain versus FMT interaction (pi < 0.05).
In addition, the mRNA levels of CCL2 (pstrain < 0.05)
(Figure 4G) and CD11b (pstrain < 0.01) (Figure 4H) were also
increased after FMT from SHR to WKY and decreased after
FMT from WKY to SHR (pFMT < 0.05), without significant
interaction (pi = 0.10).
We sought to determine whether there were alterations
in the genetic expression of olfactory receptors at the PVN.
Interestingly, we found an increase of Olfr59 (pstrain < 0.01) in
PVN accompanied by a downregulation of GPR-41 and GPR-43
(pstrain < 0.05) (Figures 5A,B) in SHR as compared to the W-W
group. FMT from WKY to SHR restored the mRNA levels of
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FIGURE 2 | Effects of fecal microbiota transplantation (FMT) on sympathetic tone. Decrease induced by acute intravenous administration of pentolinium (10 mg/kg)
on systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR), in conscious rats (A). Plasma noradrenaline (NA) levels (B), and plasma renin
activity (PRA) (C) found in all experimental groups. Strain factor, FMT factor and I interaction between strain and FMT factors. ++p < 0.01, +p < 0.05 and ns (not
significant) for the probability based on a two-way analysis of variance. Values are means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. WKY with stool transplant
from WKY (W-W); #P < 0.05 and ##P < 0.01 vs. SHR with stool transplant from SHR (S-S), statistical significance for the probability based on a Sidak’s correction
multiple comparisons test.
these receptors (pFMT < 0.01, pi = 0.37; pFMT < 0.05, pi = 0.08;
pFMT < 0.05, pi < 0.03, respectively) (Figures 5A,B).
FMT Induced Changes in the Gut
Microbiota Composition
To determine the dynamics of gut microbiota during the
exchange of gut microbiota between SHR and WKY, we analyzed
fecal DNA isolated from all experimental groups. Figure 6A
shows the bacterial taxa (class, order, family, and genus) that
were altered by fecal exchange from SHR to WKY, according
to LEfSe analysis. Prominent shifts in bacterial community were
observed after 4 weeks of treatment between the W-W and S-S
groups, with an increase in the relative abundance of 10 bacterial
taxa (green) and a decreasing of 6 taxa (red) comparing with the
W-W group. Several changes in microbial taxa were also driven
by fecal exchange from SHR to WKY with an increase in the
relative abundance of 3 bacterial taxa (green) and a reduction
of 7 taxa (red) (Figure 6B). While S-W compared to the S-S
group, only relative abundance of 2 taxa were increased (green)
and 22 were decreased (red) (Figure 6C). Interestingly, we found
an association between a major abundance of butyrate-producing
family Odoribactereae and the genus of Odoribacter with low
BP levels present in the W-W and S-W groups. In contrast,
we observed a correlation between Blautia and Peptococcaceae
abundance and elevated BP in the S-S and W-S groups (Figure 6).
When comparing the bacterial composition evolution, at the
family level, in the gut microbiota between all experimental
groups, we found that W-S had a significantly lower abundance of
Bacteroidaceae, and greater abundance of Clostridiacea in the gut
microbiota than the W-W group at 4 weeks of treatment. While
S-W showed a depletion of abundance of Lactobacillales and an
increase of Erysipelotrichaceae compared to the S-S group at the
end of the experiment (Figure 7).
Gut Integrity and Inflammation Are
Regulated by Gut Microbiota
In concurrence with previous data (Santisteban et al., 2017)
the levels of occludin (pstrain < 0.05) (Figure 8A), and zonula
occludens (ZO)-1 (pstrain < 0.01) (Figure 8B), and mucin
(MUC)-2 (pstrain < 0.05) (Figure 8C) were significantly reduced
in the S-S group as compared to the W-W group. The expression
of colonic ZO-1 and MUC-2 (pFMT < 0.05) were also reduced
when FMT from SHR to WKY was performed, which were
accompanied of a significant strain versus FMT interaction
(pi < 0.05), whereas FMT from WKY to SHR tended to increase
these parameters but without statistical significance, as compared
to the S-S group. Similarly, increased mRNA expression of
pro-inflammatory TNF-α (pstrain < 0.05) (Figure 8D) and IL-
6 (pstrain < 0.05) (Figure 8E), without significant change in
IL-1β (Figure 8F) was also observed in the S-S group as
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FIGURE 3 | Effects of fecal microbiota transplantation (FMT) on ROS production and NADPH oxidase pathway in the brain PVN. CM-H2DCFDA-detected
intracellular ROS in absence and presence of NADPH oxidase inhibitor apocynin (50 µM) (A) and NADPH oxidase activity measured by DHE fluorescence measured
in the microplate reader (B) in homogenates from brain PVN. mRNA levels of NADPH oxidase subunits NOX-1, NOX-4, p47phox and p22phox (C) in the brain PVN
from all experimental groups. Strain factor, FMT factor and I interaction between strain and FMT factors. ++p < 0.01 and ns (not significant) for the probability based
on a two-way analysis of variance. Values are means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. WKY with stool transplant from WKY (W-W); #P < 0.05 vs.
SHR with stool transplant from SHR (S-S), statistical significance for the probability based on a Sidak’s correction multiple comparisons test.
compared to the W-W group. FMT from WKY to SHR reduced
the levels of these pro-inflammatory cytokines (pFMT < 0.05,
pi < 0.05; pFMT < 0.01, pi < 0.01, respectively). We found
reduced GPR-43 mRNA levels in the gut from both SHR groups
as compared to the W-W group (pstrain < 0.05) (Figure 8G).
GPR-43 transcript level tended to be reduced in WKY rats after
FMT from SHR (pFMT = 0.057) without interaction between
strain and FMT (pi = 0.11). In addition, an increase in intestinal
permeability has been proposed as a crucial mechanism for
the development of endotoxemia (Cani et al., 2008). In fact,
we found increased plasma LPS levels Figure 8H) in rats with
high BP (W-S and S-S groups) (pstrain < 0.05; pFMT < 0.05;
pi = 0.19), qualitatively associated with impaired colonic
integrity. Interestingly, FMT transplantation from WKY to SHR
reduced plasma LPS levels despite no significant increase in gut
integrity. Furthermore, both the colonic expression of tyrosine
hydroxylase (TH) (pstrain < 0.05) (Figure 8I) and the colonic
NA concentration (pstrain < 0.01) (Figure 8J) were significantly
up-regulated in both groups that received fecal contents from
SHR. Interestingly, the long-term treatment with stool from
WKY significantly decreased both TH levels (pFMT < 0.01;
pi = 0.62) and NA content (pFMT < 0.01; pi < 0.05) in the
S-W group.
DISCUSSION
Fecal transplantation from animals (Adnan et al., 2017; Toral
et al., 2018) and subjects (Li et al., 2017) with hypertension to
normotensive animals can elevate BP. However, the mechanisms
by which bacteria control BP have not been elucidated. Our
results demonstrate, for the first time, that alteration of gut
microbiota composition induced by reciprocal FMT between
WKY and SHR influences the brain, and SNS impacting BP.
The most significant findings of this study are; (1) Microbiota
affects brain PVN NADPH oxidase activity, neuroinflammation
and sympathetic activity in both strain of rats, (2) Lower Blautia
and Odoribacter content in feces is inversely correlated with high
SBP, and (3) Loss of gut integrity in SHR seems to be independent
of sympathetic tone, BP, and microbiota composition.
It is pertinent to note that elevated SNS activity is a hallmark
of both animal and human hypertension (DiBona, 2013;
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FIGURE 4 | Effects of fecal microbiota transplantation (FMT) on brain PVN pro-inflammatory markers expression. mRNA levels of TNF-α (A), IL-β (B), IL-6 (C), IL-17a
(D), interferon-γ (IFNγ) (E), IL-10 (F), C-C chemokine ligand 2 (CCL2) (G) and macrophage marker CD11b (H) measured by RT-PCR in brain PVN from all
experimental groups. Strain factor, FMT factor and I interaction between strain and FMT factors. ++p < 0.01, +p < 0.05 and ns (not significant) for the probability
based on a two-way analysis of variance. Values are means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. WKY with stool transplant from WKY (W-W); #P < 0.05
vs. SHR with stool transplant from SHR (S-S), statistical significance for the probability based on a Sidak’s correction multiple comparisons test.
Grassi et al., 2015). Santisteban et al. (2017) observed enhanced
gut-neuronal communication in hypertension originating
from the PVN of the hypothalamus and presenting as
increased sympathetic drive to the gut. Previous studies
have also characterized hypertension with alterations in the gut
microbiota and sympathetic dysregulation (Zubcevic et al., 2014;
Yang et al., 2015; Santisteban et al., 2017). Our current study,
demonstrating both higher BP reductions after pentolinium
administration and plasma NA levels, both markers of increased
sympathetic drive, associated with microbial dysbiosis, provides
new evidence in support of that proposal. This higher SNS
activity correlates with higher SBP and DBP in the W-S group
compared to W-W. Similarly, FMT from SHR to SHR showed
higher levels of these sympathetic drive parameters than that
found in the W-W group. The changes induced by FMT from
WKY to SHR and vice versa in BP seem to be independent
of systemic renin-angiotensin system, since PRA was not
significantly affected. Moreover, increased catecholaminergic
neurotransmission has been reported in SHR, characterized by
increased TH activity as well as gene and protein expression
(Yu et al., 1996; Reja et al., 2002; Lopez Verrilli et al., 2009),
suggesting that TH plays a key role in the genesis, development
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FIGURE 5 | Effects of fecal microbiota transplantation (FMT) on brain PVN SCFA-sensing receptors expression. mRNA levels of Olfr 59 (A), GPR-41 and GPR-43 (B)
measured by RT-PCR in brain PVN from all experimental groups. Strain factor, FMT factor and I interaction between strain and FMT factors. ++p < 0.01, +p < 0.05
and ns (not significant) for the probability based on a two-way analysis of variance. Values are means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. WKY with
stool transplant from WKY (W-W); #P < 0.05 and ##P < 0.01 vs. SHR with stool transplant from SHR (S-S), statistical significance for the probability based on a
Sidak’s correction multiple comparisons test.
and/or maintenance of hypertension. In agreement with this
information, our data showed increased colonic expression of
TH and NA content from the S-S and W-S groups compared to
W-W, showing increased sympathetic activity in this tissue.
The gut microbiota influences the hosts inflammatory
response (Cani et al., 2007) and inflammation induces
oxidative stress and vice versa. In brain, angiotensin II
via an AT1 receptor mechanism activates the sympathetic
outflow by stimulation of the NADPH oxidase-dependent
ROS production (Gao et al., 2005). In brain from the S-S
group we found increased NADPH oxidase activity driven-
ROS production, expression of NADPH oxidase subunits,
pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and
sympathetic activity, as compared to W-W rats. These data
could be related to higher PRA found in the S-S group
as compared to the W-W group. Conversely, FMT from
SHR to WKY also resulted in higher PVN inflammation,
NADPH-oxidase activity and sympathetic outflow than induced
by FMT from WKY to WKY. Taken together, our data
suggest that gut microbiota is involved in the regulation of
brain inflammatory and oxidative status, and the subsequent
sympathetic activity.
The increased sympathetic activity also affects the BM
resulting in an increase in inflammatory cells, which
migrate to the PVN and enhance neuroinflammation
(Santisteban et al., 2016). Accordingly, we found increased
inflammation in brain PVN from the S-S and W-S groups,
associated to an increased expression of CCL2, which facilitates
BM cells entering the brain’s parenchymal space; CD11b, a
macrophage marker; and IL-17a, mainly produced by Th17
cells, that might contribute to neuroinflammation. Overall, all
this data showed a gut-brain communication characterized
by increased pro-oxidant, pro-inflammatory and immune
cell infiltration profile in brain PVN after FMT from SHR to
WKY. Interestingly, chronic normal microbiota transplantation
to hypertensive rats induced a stable BP reduction linked to
reduced brain PVN inflammation, NADPH oxidase activity
and sympathetic excitation. Taken together, our present results
demonstrate that hypertension is, at least in part, a result of
pathophysiological changes in the gut microbiota, affecting brain
areas of cardiovascular control such as PVN.
The mechanisms involved in the pro-hypertensive effects
of gut microbiota from SHR are unknown. There is growing
evidence that gut microbiota has emerged as an important
factor that can influence the host’s physiology through bacterial
metabolic products such as SCFAs (Pluznick et al., 2013).
Gut dysbiosis in SHR is characterized by reduced acetate-
and butyrate-producing bacteria than their WKY normotensive
counterparts (Yang et al., 2015). These SCFAs induced anti-
inflammatory effects in the gut, mediated by GPR-43 activation
(Yang et al., 2018). SCFAs, in addition to providing energy to
gut epithelium and peripheral tissues, also promote intestinal
epithelial integrity and aid in the repair of wounded epithelium,
mainly throught GPR-43 activation (D’Souza et al., 2017). We can
hypothesize that insufficient signaling through SCFAs-activated
GPR-43 pathway in the gut, mediated by both lower SCFAs-
producing bacteria and lower colonic GPR-43 expression in
SHR, can lead to compromised gut integrity, dysregulated
inflammation, and passage of substances such as LPS into the
blood. The increase in BP in SHR was associated with gut
pathology that included increased intestinal permeability and
decreased tight junction proteins (Santisteban et al., 2017). We
analyzed the integrity of the gut epithelial barrier measuring
the mRNA levels for tight junction proteins and mucins, which
are involved in mucus production, in the proximal colon.
We found that FMT from SHR to WKY significantly reduced
colonic ZO-1 and MUC-2, increased colonic TNF-α and plasma
levels of LPS. LPS might be involved in the pathogenesis of
hypertension, through toll-like receptor (TLR)-4 stimulation in
the vasculature (Liang et al., 2013), and by inducing systemic
inflammation, accompanied by microglia activation, oxidative
stress in cardiovascular regions of the brain, such as rostral
ventrolateral medulla (Wu et al., 2012) and PVN (Zhang et al.,
2010). However, high levels of plasmatic LPS, as a consequence
of an infection, can lead to septic shock and hypotension
(Bermejo et al., 2003).
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FIGURE 6 | Effects of fecal microbiota transplantation (FMT) on changes of the gut microbiome. Comparisons of microbiome changes in WKY with stool transplant
from WKY versus SHR with stool transplant from SHR (A) WKY-WKY versus WKY-SHR (B) and SHR-SHR versus SHR- WKY (C). Cladograms (top panes) show the
significantly enriched taxa, the taxa are identified in the key to the right of each pane. The larger the circles the greater the difference in abundance between the
groups. The lower panels show the results of linear discriminant analysis effect size at p < 0.05 and LDA score of > 2.5 and detail the taxa most enriched by WKY,
SHR or SHR-WKY. n = 6 animals per treatment group in each comparison.
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FIGURE 7 | Effects of fecal microbiota transplantation (FMT) on changes of composition of gut microbiota. Time-dependent changes of fecal microbiota upon in all
experimental groups (n = 6 rats per group).
On the other hand, butyrate, acetate and propionate are
metabolic products of the gut bacteria that, in addition to their
gut anti-inflammatory effects, have anti-hypertensive properties
(Natarajan and Pluznick, 2014; Pluznick, 2014; Natarajan et al.,
2016). SCFAs modulate BP through the renal and vascular
Olfr and GPRs. SCFAs modulate BP through the renal and
vascular olfactory receptor (Olfr) 59 (its stimulation elevates
BP), G-protein-coupled receptor (GPR)-41, and GPR-43 (their
stimulation both lower BP) (Pluznick et al., 2013). In addition
to the vasculature (Pluznick et al., 2013; Pluznick, 2014), the
SCFA-sensing receptors Olfr78 and GPR-43, as well as GPR-
41, are present on the sympathetic ganglia (Kimura et al.,
2011; Nøhr et al., 2015). We also found expressional changes
in PVN of the hypothalamus (a major brain region involved
in regulation of the sympathetic output) of receptors for
SCFAs, suggesting a probable connection with BP control.
Prior works have demonstrated that a high abundance of
butyrate-producing genus Odoribacter, in the gut microbiota
in pregnant women at 16 weeks gestation is associated with
decreased BP (Gomez-Arango et al., 2016). As butyrate is
able to cross the blood brain barrier (Bergersen et al., 2002;
Vijay and Morris, 2014; Sun et al., 2016) circulating butyrate
may thus have direct effects on regions of the brain that
regulate BP. Our data showed that a significant depletion of
Odoribacter in the W-S and S-S groups were noted, consequently,
this depletion might contribute to the dysregulation of the
expression Olfr59, GPR-41, and GPR-43 found in PVN from
hypertensive groups. Because Olfr59 elevates BP and GPR-
41 opposes this action to lower BP, these data support the
suggestion that the altered expression of SCFA receptors in
the PVN may play a role in elevated BP of the SHR. Several
groups have reported the presence of SCFA-sensing receptors
(i.e., Olfr59, GPR-41) in multiple organs and neural tissues
(Kimura et al., 2011; Nøhr et al., 2015). These studies also show
that expression levels of SCFA-sensing receptors in the whole
brain are relatively low (Kimura et al., 2011), but no studies to
date have specifically examined the expression of these receptors
in cardioregulatory brain regions such as the PVN of the
hypothalamus. Moreover, the effects of SCFAs on modulation of
sympathetic activity and BP have also previously been suggested.
Kimura et al. (2011) observed that intraperitoneal administration
of propionate caused a significant increase in heart rate in
the wild type, but not the Gpr41-/- mice. It is tempting to
hypothesize that the possible low plasma butyrate levels and
lower GPR-41, and GPR-43 expression found in PVN from
rats transplanted with SHR microbiota as compared to that
transplanted with WKY feces, could also contribute to increased
neuroinflammation and sympathetic outflow in these animals.
However, neither plasma nor brain levels of SCFAs have been
measured in the present study, which limit the real role of
SCFAs in the control of sympathetic output. Clearly, additional
studies are necessary to confirm this hypothesis and provide a
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FIGURE 8 | Effects of fecal microbiota transplantation (FMT) on colonic pro-inflammatory, epithelial integrity, and sympathetic activity markers. Colonic occludin (A),
zonula occludens-1 (ZO-1) (B), mucin (MUC)-2 (C), TNF-α (D), IL-6 (E), IL-β (F) and GPR-43 (G) mRNA levels, plasma endotoxin concentrations (EU/mL, endotoxin
units/mL) (H), mRNA levels of tyrosine hydroxylase (TH) (I), and noradrenaline (NA) content (J), in all experimental groups. Strain factor, FMT factor and I interaction
between strain and FMT factors. ++p < 0.01, +p < 0.05 and ns (not significant) for the probability based on a two-way analysis of variance. Values are
means ± SEM (n = 5–8). ∗P < 0.05 and ∗∗P < 0.01 vs. Wistar-Kyoto (WKY) with stool transplant from WKY (W-W); #P < 0.05 and ##P < 0.01 vs. SHR with stool
transplant from SHR (S-S), statistical significance for the probability based on a Sidak’s correction multiple comparisons test.
mechanism for the differential regulation of these SCFA receptors
throughout the SNS.
Furthermore, we found in the W-S group a depletion of
Peptococcaceae, a sulfate-reducing bacteria considered to be
beneficial in the regulation of BP (Ahmad et al., 2012; Yu et al.,
2018). Sulfate-reducing bacteria, and hydrogen sulfide released
in the colon may also contribute to the control of arterial BP,
being antihypertensive, at least in part, through suppression of
sympathetic outflow (Duan et al., 2015). The genus Blautia, which
is the main bacterial group in Clostridium coccoides-group, was
also found to decrease in Japanese patients with type 2 diabetes,
as compared with control subjects (Sato et al., 2014).
Interestingly, transplantation of gut microbiota from WKY
to SHR reduced gut inflammation, plasma LPS levels, brain
PVN inflammation, NADPH oxidase activity and sympathetic
excitation, leading to a stable drop of BP. However, no significant
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improvement of colonic integrity was found in this group as
compared to the S-S group. Sympathetic activity influenced
these gut parameters (ZO-1, occludin, MUC-2), via top-
down signaling (Santisteban et al., 2017). However, normalized
sympathetic activity to the gut (lower TH transcript level
and NA content) without correction of gut parameters, in
the SHR with a WKY microbiota, is in conflict with this
hypothesis. The lack of protective effects in the gut integrity
could be related to the lower expression of GRP-43 found
in colonic tissue from this group, and subsequent lower
GRP-43 pathway activation despite the possible increase in
gut SCFAs induced by FMT from WKY. A similar loss of
gut integrity has been found in young prehypertensive SHR
despite no gut dysbiosis being detected in these animals
(Santisteban et al., 2017). Overall, gut integrity in SHR
seems to be independent of sympathetic tone, BP, and
microbiota composition.
CONCLUSION
In conclusion, in this genetic model of hypertension
(SHR) gut dysbiosis correlates to sympathetic outflow
via stimulation of NADPH-oxidase-derived ROS in the
brain. These central effects seem to be associated with
reduced expression of butyrate-sensing receptors in the
hypothalamus, Th17 and macrophages infiltration in PVN
and higher plasma levels of LPS. These results are congruent
with evidence from previous studies suggesting a strong
correlation between hypertension and gut microbiota dysbiosis,
establishing a cause-effect relationship between elevated
BP and altered gut microbiota. We can speculate that
changes in gut microbiota through the use of probiotics
in treating gut dysbiosis could have positive effects on
neurogenic hypertension, through modulation of central
sympathetic activity.
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